Five-year analysis from the ESPRIT 10-year postmarketing surveillance registry of adalimumab treatment for moderate to severe psoriasis
Author:
Publisher
Elsevier BV
Subject
Dermatology
Reference24 articles.
1. Long-term prognosis in patients with psoriasis;Gulliver;Br J Dermatol,2008
2. National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening;Kimball;J Am Acad Dermatol,2008
3. Incidence of cardiovascular disease in individuals with psoriasis: a systematic review and meta-analysis;Samarasekera;J Invest Dermatol,2013
4. Psoriasis severity and the prevalence of major medical comorbidity: a population-based study;Yeung;JAMA Dermatol,2013
5. Prevalence of cardiovascular risk factors in patients with psoriasis;Neimann;J Am Acad Dermatol,2006
Cited by 53 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A randomized, double-blind phase III study to demonstrate the clinical similarity of biosimilar SCT630 to reference adalimumab in Chinese patients with moderate to severe plaque psoriasis;International Immunopharmacology;2022-11
2. Secukinumab long-term efficacy and safety in psoriasis through to year 5 of treatment: results of a randomized extension of the phase III ERASURE and FIXTURE trials;British Journal of Dermatology;2022-10-21
3. Risk of respiratory tract infections and serious infections in psoriasis patients treated with biologics: Results from the BioCAPTURE registry;JEADV Clinical Practice;2022-06-24
4. A Randomized, Double-Blind Phase III Study to Demonstrate the Clinical Similarity of Biosimilar SCT630 to Reference Adalimumab in Chinese Patients with Moderate to Severe Plaque Psoriasis;SSRN Electronic Journal;2022
5. Correlation of Immunological and Clinical Changes in Psoriasis Patients Treated with Tumour Necrosis Factor-Alpha (TNF-α) Blocking Biologic Drugs: One-Year Dynamic Observation;Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.;2021-10-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3